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Methamphetamine is a stimulant and drug of abuse. Its use has
shown a recent reemergence nationwide, most notably in Hawaii.
Much of this increase is accounted for by smokable crystallized
methamphetamine “‘ice”. Its acute effects include cardiovascular
and psychiatric disturbances. Chronically, structural and functional
brain damage may occur. Psychosis may occur acutely or chroni
cally, and sometimes even in abstinent patients.
Case Report
Ms. B. is a 30-year-old woman who presented to the emergency
department of a major urban hospital in Hawaii, asking for “drug
detox”. She stated that she came in because she felt suicidal after
relapsing from about 2 weeks of abstinence from crystal metham
phetamine use. She had recently been admitted to an inpatient drug
treatment facility, and had left against medical advice 3 days prior
to presenting to the emergency department. She stated that she had
felt that she was “strong enough to stay off ice”; however, she soon
encountered someone with whom she had used ice in the past.
Immediately thereafter, they went to buy and then smoke crystal
methamphetamine (ice). The patient denied any other psychoactive
drug use in the past 2 weeks. She presented at 6 am on a Sunday,
about 6 to 8 hours after having last used ice.
Ms. B. admitted to problems with alcohol in the past, but denied
using much alcohol since starting to smoke ice about 6 months ago.
She had been seeing a psychiatrist for supportive psychotherapy.
She had recently separated from her husband and has been
homeless since leaving the inpatient facility 3 days ago. Ms. B.
reported that she had been staying with friends since then; she
admitted that some of these friends also use ice. The patient stated
that she was taking cimetidine for gastrointestinal reflux, but was on
no other medications and had no other medical problems.
On physical exam, the patient was fatigued and somewhat dishev
eled. Her pulse was 126, blood pressure was 145 over 88, respira
tions were 24 per minute, and temperature was 100.4 degrees
Fahrenheit. Her pupils were reactive and 5 mm bilaterally. She
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exhibited no signs of head trauma. At rest, she had a fine tremor of
the hands. She had mild hyperreflexia, but exhibited no focal
neurological deficits, and the remainder of the exam was normal.
Behaviorally, the patient was noted to be restless and did not
maintain eye contact. She was often uncooperative with the exam.
Her speech was pressured, but normal in volume. Her mood was
irritable; her affect was mood-congruent but constricted. She admit
ted to both auditory and visual hallucinations, stating that she had
been seeing shadows and hearing voices which she described as
“mumbo jumbo.” Her thought processes were disorganized and
often tangential. She was occasionally paranoid about various
friends. She was oriented to person, but not to place or time.
Cognitively, she exhibited markedly diminished memory for recent
events. The patient did not exhibit violent tendencies, and she
denied current homicidal ideation, but she did admit to throwing
rocks at parked cars earlier in the morning. She also reported
fleeting thoughts ofjumping in front of a bus over the past 12 hours.
On laboratory examination, the patient’s qualitative urine toxicol
ogy screen was positive for methamphetamine and benzodiaz
epines.
The patient was given risperidone, 1 mg orally, and was then
observed in the emergency department for 3 hours. As she continued
to exhibit suicidal and paranoid thoughts, she was admitted volun
tarily to a locked psychiatric ward for treatment. She progressed
well in the hospital and was discharged after 4 days with instructions
to follow up with a rehabilitation program. The patient was subse
quently lost to follow-up.
Introduction and History
Methamphetamine is a synthetic amine belonging to the amphet
amine class of drugs. It has stimulating effects on both the central
and peripheral nervous systems. Although they have been and
continue to be prescribed by physicians, amphetamines are increas
ingly being used for illicit purposes, both in the U.S. and abroad.
Unfortunately, although methamphetamine is a chemical that does
not occur in nature, it is all too easy to obtain or to synthesize
(detailed instructions for doing so can be obtained over the Internet).
Originally synthesized in 1887 by a German chemist, it was not
until the 1930’s that amphetamines became used therapeutically.
During the 1930’s and 40’s, amphetamines of various types were
promoted by American pharmaceutical companies as therapeutic
for a number of ailments, supposedly without any risk of addiction.
Over the same period, in Japan, large quantities of methamphet
amine, mostly in pill form, were manufactured for domestic con
sumption. After the war, Japanese pharmaceutical companies fol
lowed the lead of their American counterparts, launching a large
promotional campaign for over-the-counter methamphetamine pills
that were in abundance at former military warehouses. Thus it came
to be in Japan that the first large-scale epidemic of methamphet
amine use occurred.1
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In the U.S., where a prescription was still needed to legally obtain
amphetamines, the epidemic was slower in coming. However, by
the 1950’s, nonmedical use of amphetamines had spread to the
civilian population, mostly those in need of stimulation to keep
awake or fend off boredom in repetitive or monotonous tasks. Not
surprisingly, truck drivers, college students, athletes, and house
wives made up the first major wave of amphetamine abusers in the
U.S. At the same time, prescription amphetamines, including meth
amphetamine, continued to be promoted as therapeutic for hyperac
tivity, obesity, narcolepsy, and depression.2
In the 1960’s, intravenous use of methamphetamine became more
popular, especially among those who had already been using illicit
drugs. This group was apparently the first to use methamphetamine
solely for its euphoric effects, rather than for its stimulating or
anoretic properties. This “second wave” of the American epidemic
was largely held in check through law-enforcement and public
health efforts to educate and treat abusers and potential users. Japan
had similar campaigns, with particularly stiff penalties for drug
manufacture or importation.3
However, by the mid-1980’s in the U.S. (and even earlier in
Japan), a rapid increase in methamphetamine abuse began. This
“third wave” began with the introduction of a potent, smokable form
of crystal methamphetamine, known as “crystal”, “glass”, or “ice”
on the street. In the Philippines, and among the Filipino expatriate
communities in the U.S. (especially in Hawaii), it has been known
as batu (Tagalog for “rock”).
This newer form has been gaining in popularity over the intrave
nous form due to its ease of use, and over the oral form due to its
rapidity of CNS effect (and thus a more potent “high”). It has also
attracted users of “crack” (smokable cocaine), due to the longer
duration of the “high” or “rush”. In fact, users of crack cocaine
report being unable to distinguish the clinical effects of crystal
methamphetamine (ice) from that of crack.4 In Hawaii, where
crackdowns on marijuana production and sale have recently taken
place, part of the boom in crystal methamphetamine use may be due
to lesser availability of marijuana and other drugs.
Epidemiology
The routes of administration of methamphetamine include oral,
intravenous, and by inhalation of its smoke. According to a study
done in three American cities in 1994, the total number of users
employing each of the three modes ofuse was nearly equal (i.e., one-
third each). Of note, however, was that the percentage of metham
phetamine users in the Honolulu group who preferred the smokable
form was 92% (versus 10% for San Diego and 8% for San Fran
cisco).5 This suggests an altogether different epidemic in Hawaii
compared to the Mainland.
The reasons for this difference are unclear, but there are some
other interesting differences between the usage patterns in Hawaii
versus the Mainland: users in Honolulu were significantly younger,
less educated, much more likely to come from a family in which the
parents used marijuana or cocaine, and more likely to have begun
using methamphetamine recently. Those in the Honolulu group
were also more prone to violence, assaults, shoplifting, money
problems, and weight loss.5
There were also differences in age and ethnic background, but it
is difficult to assess whether this is due to the different composition
of the Hawaiian population. In a study looking at ice users on Oahu,
the using population was more likely to be young (59% under age
20, compared with only 30% in the population at large). Addition
ally, Filipinos, Hawaiians and part-Hawaiians were represented
disproportionately (23% of users were Filipino versus 12.6% in the
general population, while 35% were Hawaiian/Part-Hawaiian, who
representjust 10.7% of the population, according to census figures).
Japanese, Korean, Chinese, Caucasian, Hispanic, and Black were
all underrepresented ethnicities.6However, it is worth keeping in
mind that data for ethnic background were self-reported, and thus
could be susceptible to bias.
Acute Effects
The acute clinical effects of all psychostimulants, including the
amphetamines and cocaine, are strikingly similar.7Methamphet
amine differs in its sympathomimetic actions from other amphet
amines in that it exerts fewer peripheral effects (e.g., tachycardia)
and more CNS effects (e.g., euphoria), possibly due to a higher CNS
penetration.2
The physical, or peripheral effects of methamphetamine are
mediated by the autonomic nervous system and include: tachycar
dia, tachypnea, tremor, hypertension, dry mouth, mydriasis, and
blurry vision. The mechanism for these effects appears to be
methamphetamine’s ability to stimulate release of norepinephrine
at nerve terminals and of epinephrine from the adrenal medulla.8
Potentially lethal toxicities of methamphetamine overdose are
most commonly seen in first-time users who take a single, large
dose.8 Worrisome symptoms include hyperthermia, arrhythmias,
and marked hypertension. Permanent neurological sequelae may
also occur: cerebral infarcts can result from ischemia or hemorrhage
secondary to a sudden, massive increase in blood pressure; also,
direct neurotoxicity can result from central hyperthermia, which is
easily exacerbated by increased muscular activity in agitated pa
tients.2 In addition, myocardial infarction and acute pulmonary
edema have been associated with methamphetamine ingestion.9”°
The central effects ofmethamphetamine apparently result from its
structural similarity to the catecholamine neurotransmitters that are
active in the CNS (e.g., epinephrine, norepinephrine, and dopam
me).4 Behaviorally, users of methamphetamine report increased
energy, perception, self-confidence, and sexuality, as well as a
sense of euphoria.7 However, they also commonly experience
irritability, impulsivity, impaired judgement, and insomnia, as well
as such non-behavioral CNS effects as nausea, dizziness and anor
exia. Psychotic behaviors such as hallucinations and paranoia are
other potentially dangerous manifestations of acute toxicity, and
can lead to irrational, suspicious, and often violent behavior, which
may persist for days or even weeks.2 The risk of homicidal or
suicidal attempts is significant in such patients.1 These patients
pose a special challenge to care providers in the emergency setting,
as the psychosis is often clinically indistinguishable from paranoid
schizophrenia. One characteristic feature of these psychotic epi
sodes is that, like drug-induced psychoses in general, they fre
quently involve vivid visual or tactile hallucinations.8
Chronic Effects
Chronic abuse of methamphetamine can lead to neuron loss
secondary to microvascular damage, as well as to a depletion of
dopaminergic neurons, both of which may be permanent8 An
example of a sequela that may be due to this effect on dopaminergic
neurons, ostensibly on those in the substantia nigra, is the movement
disorders that are sometimes seen in patients using methamphet
amine, as well as in those who have quit.
Another effect of chronic abuse of methamphetamine is the CNS
“kindling” phenomenon, also referred to as “reverse tolerance”.
Patients who have used amphetamines over a long period, espe
cially those who have had psychotic episodes from its use, may be
pushed into a frank psychosis by even very small amounts of an
amphetamine (or indeed by any psychostimulant, including caf
feine and nicotine).8’12 The mechanism for this kindling phenom
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enon is uncertain, but it may involve alterations in dopaminergic
sensitivity of the striatum.’ This is discussed further in the next
section.
Some investigators also point to the existence of a chronic
psychosis, termed “withdrawal” or “abstinence” psychosis, second
ary to long-term use of amphetamines. However, some believe that
these patients should be considered to have had latent schizophrenia
that may have been brought out, rather than caused de novo, by
amphetamine use.’3’14
Tolerance and Sensitization
Tolerance develops for some of the effects of methamphetamine,
especially those acting via the peripheral nervous system, as well as
for certain CNS effects (such as euphoria, anorexia, and hyperther
mia).7 However, the reverse is true for effects on judgement,
impulsivity, aggression, and susceptibility to paranoia, delusions,
and hallucinations. In other words, while it takes more and more
drug to achieve a desired high, and while these users acquire a
decreased sensitivity to tachycardia and hypertension, they are
actually more likely to exhibit pathological, often violent or self-
destructive behavior even with no escalation in dose (or indeed with
a decrease).8This sensitization illustrates the effect of the kindling
concept mentioned above. Further, since tolerance develops rela
tively rapidly, users often end up at doses 50 or 100 times greater
than the dose they began with. Although they are physically better
able to handle these massive doses than would be a drug-naive
subject, psychologically they are actually less so. In fact, the relative
lack of significant physical effects may give some users a false sense
that they can “handle” the dose.
Addiction and Withdrawal
The degree to which methamphetamine is addictive depends
greatly on the type and route of administration. Methamphetamine
taken by a method that delivers a large bolus of active drug to the
brain all at once, such as the IV or smokable forms, gives a much
more intense, albeit shorter-acting, euphoria than does the ‘tradi
tional’ oral form. Both of these pharmacodynamic differences
contribute to the stronger potential for addiction of the rapid-acting
formulations: users of these forms get the most positive reinforce
ment for taking the drug, due to stronger associations between
administering the drug and experiencing pleasurable feelings. Thus,
smoked methamphetamine (ice) is, as one would expect, much
more addictive than oral methamphetamine, which is in turn twice
as addictive as amphetamine.2
One would also expect smokable methamphetamine to be similar
in its addictive potential to smokable cocaine (crack), given that
their euphoric effects are virtually indistinguishable. However, the
duration of euphoria with ice smoking is much longer than it is for
crack smoking (subjective half-life is about 5 hours for metham
phetamine, versus only about 50 minutes for cocaine).8This differ
ence would be expected to cause crystal methamphetamine to be
less addictive than crack, but this remains to be proven in humans.
Patients who are dependent on methamphetamine and then dis
continue use suddenly are prone to both psychological and physical
withdrawal. The psychological reaction can vary from vague feel
ings ofmalaise to cravings to extreme agitation or depression. Later,
more physical symptoms, such as polyphagia and hypersomnolence
commonly occur. Depressed mood and energy level may be pro
tracted for as long as 4-6 months in severely dependent patients.2
Patients frequently return to using amphetamines partly as a way of
dealing with these withdrawal symptoms, even after their craving
for the drug is gone.
Treatment
The road to recovery in methamphetamine abuse, as with any
psychoactive substance, is a long and treacherous one. Initial efforts
focus on gathering information and treating acute symptoms, espe
cially psychosis and cravings, as well as acute medical conditions
brought on by methamphetamine use. As the patient progresses
through the various stages of recovery, increasing emphasis is
placed on social and behavioral interventions.
The first 4 to 6 days after the patient’s most recent methamphet
amine use represent the detoxification period. This may be under
gone as an inpatient if the patient is significantly toxic. Early in this
interval, it is essential that a full medical workup be performed, as
many of the acute effects of amphetamines are potentially lethal.
Vital signs should be checked frequently, and blood pressure
controlled to prevent end-organ damage. Initially, an EKG should
be obtained on all patients with signs of toxicity; such patients may
also need to be placed on seizure precautions.
If the patient is acutely suicidal, homicidal, or floridly psychotic,
he or she may require admission to a locked psychiatric ward. In
patients with significant agitation or current psychotic features,
risperidone, 1 mg orally, or haloperidol, 1-2 mg intramuscularly,
may be given every 12 hours as needed. If drug craving is the major
problem, as evidenced by hypothermia and subjective reports from
the patient, low-dose amantadine or bromocriptine may be tried,
although these can bring out or aggravate psychotic features.
Conversely, neuroleptics can induce increased drug craving. A less
effective, but often better-tolerated treatment for craving is to
replenish amino acids needed in the synthesis of neurotransmitters
depleted by chronic stimulant use; these are marketed as combina
tion preparations such as Tropamine and Renew.’5 Acute absti
nence-induced depression can sometimes be aborted by any of the
tricyclic or seratonin-specific antidepressants, the latter being pre
ferred for their relative lack of cardiac effects.
After the first week or so, the patient has largely recovered from
the physiologic part of the addiction, and nonmedical interventions
become foremost in importance to combat the psychological addic
tion, which is often much more problematic. These interventions
may include daily twelve-step meetings, changing one’s life-style
to eliminate contact with friends who use, and making specific goals
and commitments to maintain abstinence. By this stage, success is
largely in the hands of the patient, and many patients relapse and
start the process over many times before achieving a sustained
recovery.
Conclusions
The Hawaiian epidemic of smokable crystal methamphetamine
represents a serious public health and public safety threat. It remains
to be seen whether this represents cultural and socioeconomic
conditions unique to Hawaii, or whether this is merely the first
outbreak of a national pandemic. Some signs point to the latter,
including recent increases in use of smolable methamphetamine in
West Coast cities.’6It will be extremely important to monitor usage
patterns in Hawaii and on the Mainland in order to help formulate
effective public health and law enforcement policies.
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the top. I turned to discover he was covering both
eyes.
Richard Klein, Toronto Stitches
September ‘96
Quotable Quotes
“I feel that if I stop working I’ll get old. My
father, Dr Sidney Kirby, used to say that when
he was still working in his 80’s. (Mid Pac CC
“Rub of the Green” member profile Claire
Simpson quote). (Sidney Kirby was medical di
rector at Kalaupapa in the 1950’s and died in
1981 when he was 96-years-old).
“When a man sits with a pretty girl for an hour,
it seems like a minute. But let him sit on a hot
stove for a minute—and it’s longer than any hour.
That’s relativity.” Albert Einstein
(Gleanedfrom the Medical Arts Press
Newsletter Sept/Oct 96)
“If you want to recapture your youth, just cut
off his allowance.” Al Bernstein
“Music washes away from the soul the dust of
everyday living.” Leopold Stokowski
“The best executive is the one who has sense
enough to pick good men to do what he wants
done, and self restraint enough to keep from
meddling with them while they do it.”
Theodore Roosevelt
“Which pharmaceuticals company will find a
sure cure for impotence?” asks comic Paul Ryan.
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“Speaking for joke writers everywhere, I hope
it’s Upjohn.”
Quoted in Los Angeles Times
A candidate came home late one night and gave
his wife the glorious news.
“Darling, I’ve been elected!”
“Honestly?” she replied exuberantly.
“Hey,” he said, “why bring that up?”
Contributed by Cathryn Hopkins
Overheard: “The trouble with getting to work
on time is that it makes the day so long.”
Edgar Argo in National Enquirer
“Youth is a wonderful thing. What a crime to
waste it on children.”
George Bernard Shaw
Points to Ponder
Young writers often suppose that style is a
garnish for the meat of prose, a sauce by which a
dull dish is made palatable. Style has no such
separate entity; it is nondetachable, unfilterable.
The beginner should approach style warily, real
izing that it is himselfhe is approaching, no other;
and he should begin by turning resolutely away
from all devices that are popularly believed to
indicate style—all mannerisms, tricks, adorn
ments. The approach to style is by way of
plainness, simplicity, orderliness, and sincer
ity.
E.B. White “Elements ofStyle”
Sketches from Stitches
What Can You Say?
Recently one of my well known middle aged
female patients presented urgently to the office.
“I have a headache,” she said, “but I don’t know
what it is because there isn’t much in there to
hurt.”
Marie Cescon MD, Woodville Ont.
High Tech Exam
John, yet in his 30’s was concerned about
prostate cancer. His father was found to have the
condition and he had spent hours in a urologist’s
office reading pamphlets on prostate cancer and
its prevention.
“I’m sorry,” he said, “but could you tell me
what tests I need to check for prostate cancer.”
“A blood test and a rectal exam,” I repeated.
“OK, OK, But if I’m really at risk, I don’t want
just any rectal exam. I want one of those new
digital ones”
I. W. Tobson MD, White Rock; B. C.
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Extra copies of the Hawaii Medical
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Domestic Violence and the Decem
ber Special issue on Death and Dy
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